ABEMA Alone or in COMBO With MK-6482

NCT04627064 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Clear Cell Renal Cell Carcinoma

Interventions

DRUG: Abemaciclib
DRUG: MK-6482

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]